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Abstract. The addition of exogenous hepatocyte growth 
factor (HGF)/scatter factor (SF) to MDCK epithelial 
cells results in fibroblastic morphology and cell motil- 
ity. We generated HGF/SF producing MDCK cells by 
transfection with an expression plasmid containing hu- 
man HGF/SF eDNA. Production of HGF/SF by these 
cells induced a change from an epithelial to a fibro- 
blastic morphology and increased cell motility.  In ad- 
dition,  the HGF/SF producing cells acquired efficient 
anchorage-independent  growth in soft agar but did 
not form tumors in nude mice.  The morphological 
change and the stimulation of the anchorage-indepen- 
dent growth were prevented by anti-HGF/SF antibody, 
suggesting that the factor is secreted and then exerts 
its effects through cell surface receptors. 
C 
ELL dispersion and motility are required for normal 
embryogenesis and tissue remodeling,  and are also 
important steps in the invasion of tumor cells (Rosen 
and Goldberg,  1989).  The molecular mechanisms respon- 
sible for the induction of cell dispersion and cell motility re- 
main unclear. Several factors affecting cell motility have been 
discovered (Rosen and Goldberg, 1989). Among them, scat- 
ter factor (SF),  ~ a mesenchymal cell-derived protein,  dis- 
sociates epithelial cell colonies to individual cells and stimu- 
lates the migration of epithelial cells (Stoker and Perryman, 
1985; Stoker et al., 1987; Gherardi et al., 1989). Since im- 
plantation of SF-producing  human fibmblasts into chick em- 
bryos caused abnormal development, it was suggested that 
SF is involvedin embryogenesis (Stem et al., 1990). Purified 
SF promotes the invasiveness  into collagen  matrices of a 
number of human carcinoma cell lines,  suggesting that SF 
is involved in the invasion  of tumor cells (Weidner  et al., 
1990). 
Recently,  scatter factor has been found to be identical  to 
hepatoeyte growth  factor (HGF)  (Weidner et al.,  1991). 
HGF was originally identified as a potent mitogen for hepa- 
tocytes in primary culture (Gohda et al.,  1988; Nakamura 
et al.,  1987; Zarnegar and Michalopoulos,  1989).  HGF is 
also mitogenic in melanocytes and endothelial  and epithelial 
cells (Rubin  et al.,  1991). Moreover,  the same factor was 
purified from the culture medium of human embryonic lung 
fibroblasts  as a  cytotoxie factor in some tumor cell lines 
(Higashio  et al.,  1990).  Thus, HGF has a broad spectrum 
L  Abbreviations used in this paper: HGF,  hepatocyte growth factor; SF, 
scatter factor. 
of activities  among  its various target cells.  To simplify the 
multiple names of this factor, we will refer to it as HGF/SF 
in this paper. We and others have cloned and sequenced the 
eDNA for human and rat HGF/SF (Miyazawa et al.,  1989; 
Nakamura et al.,  1989;  Tashiro  et al.,  1990;  Okajima et 
al., 1990). Human HGF/SF is synthesized as a single 90-kD 
precursor,  whose  NH2-terminal  31  amino  acid  residues 
probably function  as a  signal  peptide (Yoshiyama et al., 
1991). The precursor is glycosylated  and cleaved at a specific 
proteolytic site to yield a 65-kD heavy chain  and a 35-kD 
light chain,  which are linked together by a disulfide  bond. 
The dog kidney epithelial  cell line,  MDCK, is a highly 
sensitive target and has been used in a bioassay for the factor. 
In tissue culture,  MDCK cells form tight epithelial  mono- 
layers with junctional complexes (McRoberts et al.,  1981). 
When added to cultured MDCK cells, purified SF causes the 
breakdown of  intercellular junctions and a transition  from an 
epithelial  to  a  fibroblastic  morphology  (Gherardi  et  al., 
1989; Weidner et al.,  1990).  It also stimulates  the motility 
of MDCK cells (Stoker,  1989). 
To determine the potential autocrine role of  HGF/SF in the 
acquisition  of scattering and motile phenotypes at the single 
cell level, we introduced a plasmid that directs the constitu- 
tive synthesis of  human HGF/SF into MDCK epithelial cells. 
Cells producing human HGF/SF were converted morpholog- 
ically to fibroblast-like  scattered cells and became motile. 
These cells also acquired efficient growth property in soft 
agar. Since the morphological change and the stimulation of 
the growth in soft agar were prevented in the presence of  anti- 
HGF/SF antibody,  the factor is secreted and then exerts its 
effects through  receptors on the cell surface. 
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Materials 
Reagents were obtained as follows: restriction endonucleases from Takara 
Shuzo Co. (Kyoto, Japan) and Toyobo Co. (Osaka, Japan); the Klenow frag- 
ment of Escherichia coli DNA polymerase I from Boehringer Mannheim 
(Indianapolis,  IN); Geneticin (0418) from Gibeo Laboratories (Grand Is- 
land, NY); beparin-scpherose from Pharmacla LKB Biotechnology  Inc, 
(Piscataway, NJ); human EGF from Wakunaga Co. (Osaka, Japan). Recom- 
binant  human HGF/SF and anti-human  HGF/SF polyelonal and monoelonal 
antibodies were provided from the Research Center, Mitsubishi Kasei Co. 
(Yokohama, Japan) (Strain et al., 1991). An ELISA kit for human HGF/SF 
was provided by Dr.  S.  Shin, Otsuka  Assay  Laboratories, Otsuka  Phar- 
maceutical Co.  Ltd.  (Tokushima,  Japan) (Tsuboachi  et al.,  1991). 
Plasmid Construction 
The  N2  vector  (Armentano et  al.,  1987),  containing the  neomycin- 
resistance (Neo  R) gene, was provided by Dr. E. Gilboa (Memorial Sloan- 
Kettering Cancer Center). The 2.8-kbp BamHl fragment, containing  the en- 
tire coding region of human HGF/SF eDNA, was excised from the human 
HGF expression plasmid pSR~hHGF (Miyazawa el ai., 1991), and ligated 
into the BamHI site of pUC18. In the plasmid, the SaiI site in the polylinker 
sequence of the vector was located upstream of the 5' end of the eDNA. The 
pucIg-hHGF plasmid was partially digested at the one BamHI site corre- 
sponding to the 3' end of the eDNA. Two nucleotides were added to the 
cleaved BamHI site using the Klenow fragment of DNA polymerase L The 
linear DNA was digested with SaiI and the fragment containing the eDNA 
was isolated.  The 0.6-kbp HindlII-XboI fragment, containing the SRa pro- 
moter sequence, was excised from the pcDL-SRa296 vector ('Ihkebe et aL, 
1988), and ligated into the Hindlll-XhoI site of pBluescript.  The plasmid 
was digested with BamHI and two nucleotides were inserted into the site 
using the Klenow  fragment of DNA pulymerase L The linear DNA was 
digested with XhoI and the fragment  containing the SRc~ promoter sequence 
was isolated,  The resultant two fragments were ligated into the XhoI site 
of the N2 vector which was filled in with two nucleotides. 
Cell Culture and Transfection 
MDCK cells were obtained from American Type Culture Collection (Rock- 
villa, MD). A subclone which exhibited epithelial morphology was selected 
by limiting  dilution and transfeeled.  The cell line was cultured in DME sup- 
plemented with 5% F'BS. Cells ware transfected by electroporation. 15 ~g 
of plasmid DNA was mixed with 5 ￿  106 cells in 0.5 ml DME and pulsed 
once at 1,000 V (capacitance, 35 #F) in a cuvette (0.4 cm gap) at room tem- 
perature, 3 d after transfeetion, cells were cultured in selective medium con- 
raining the neomycin analogue O418 (800 ~tg/ml). After 14-18 d, resistant 
colonies were selected and cultured in selective medium. 
ELISA and lmmunoblot Analysis of  Human HGF/SF 
The level of HGF/SF in the conditioned medium from each transfectant was 
quantitatively measured using an ELISA kit with native human HGF as a 
standard, The cells were grown to confluence in 24-well  plates and the 
secreted HGFISF in 1 ml of the medium after 24 h culture was measured 
by ELISA.  For immunobiot analysis,  HGF/SF was partiaily purified  by 
heparin-Sepharose. Conditioned medium (2 ml) was incubated with 10 ~l 
of heparin-Sepharose (1:I, swollen in 20 mM "lYis-Cl (pH 7.4) containing 
0.15 M NaC1) overnight at 4"C with gentle agitation.  The haparin-scph- 
arose was collected by centri~..gation, and washed with 20 mM Tris-Cl (pH 
7.4) containing 0.15 M NaC1 and 0.013% CHAPS. Sample buffer (20 mM  rig~rot 
Tris-C1 (pH 6.8) containing 2% SDS, 2% 2-mereaptoethanol, 40% glycerin 
and 0.2% bromophenol blue) was added to the washed haparin-Sepharose,  0 
and boiled for 5 rain. The elated proteins were separated by SDS-PAGE on  2 
a  10% potyacrylamide gel,  After SDS-PAGE,  proteins were transferred  5 
to a  PVDF  nmmbrane (Bio-Rad  Laboratories,  Cambridge,  MA).  The  20 
filter was immunoblotted as described previously (Miyazawa el al., 1991).  50 
The color was  developed by soaking the filter in TMBiue (Transgenic  100 
Science Inc, Worcester,  MA).  200 
40O 
Soft Agar Colony Assay 
Cells, 2  ￿  103, were suspended  in Imt DME containing 10% FBS and 
0.33% Noble agar (Difeo Laboratories, Detroit, MI), and plated onto the 
same medium containing 0.5%  Noble ager to each well of a 6-well plate. 
Human HGF/SF,  human EGF,  or polyclonai  anti-HGF/SF antibody was 
added to the cell suspension before they were plated. 1 d after incubation, 
1 ml DME containing 10% FBS was added, and the medium was changed 
at intervals of 7 d. The number of colonies greater than 0.2 mm in diameter 
was counted at 28 d. 
Cell Motility Assay 
The assay was performed by standard methods using blind-well chambers 
(B-02; Labo Science,  Tokyo, Japan) and 8/~m nucleopore filters (Stoker, 
1989). Filters soaked  in collagen type IV were placed between the lower 
wells containing 0.2 mt of DME with 10% FBS and the upper wells contain- 
ing 0.1 ml of 106 cells/ml. After incubation for 5 h, the filters were fixed 
and stained with hematoxylin, and nonmlgrating cells that had accumulated 
on the upper surface were removed. Nucleated cells that migrated through 
the filters were counted on micrographs at a magnification  of x100. 
Results 
Stimulation of  Anchorage-independent Growth of 
MDCK Cells by HGF/SF 
HGF/SF was characterized by its ability to induce the dis- 
ruption and scattering of epithelial colonies and to increase 
the movement of individual MDCK cells (Stoker and Perry- 
man,  1985).  These characteristic  changes occur without 
affecting growth of the cells (Gherardi  et al.,  1989),  even 
though HGF/SF is mitogenic in some other epithelial  lines 
(Rubin et al.,  1991). Although  it has  been reported that 
MDCK cells form colonies in semisolid medium (Stiles et 
al., 1976), the effect of HGF/SF on anchorage-independent 
growth has not been extensively studied. We therefore inves- 
tigated  whether HGFISF stimulates  the growth of MDCK 
cells in soft agar. MDCK cells formed colonies in soft agar 
with an efficiency of ,'~5 %, even in the absence of HGF/SE 
However, the growth of MDCK cells in soft agar was slow 
and colonies were very small  even after 28 d  in culture 
(smaller than 50 #m in diameter).  In the presence of HGF/SF 
the growth of MDCK cells in soft agar was stimulated  in a 
dose-dependent manner between 2 and 200 ng/ml (Table I). 
Colonies were much larger after 28 d in culture than those 
of untreated  MDCK cells. 
Production of  HGF/SF  by MDCK Cells Transfected 
with Human HGF/SF cDNA 
An expression plasmid was constructed in which the human 
HGF/SF eDNA sequence was placed downstream of the 
Table L Stimulation of Growth of  MDCK Cells in Soft Agar 
in Response to Exogenously Added HGF/SF 
Concentration of  Number of Colonies 
HGF/SF added  (Efficiency) 
% 
o(o) 
o(o) 
4  (o.2) 
20 (1.0) 
24 (1.2) 
33 (1.6) 
38 (1.9) 
37 (1.8) 
Colonies larger than 0.2 mm in diameter were counted after 28 d in culture. 
Note that MDCK colonies were detected in soft agar even in the absence of 
HGF/SF but they were very small (smaller than 50 tzm). Numbers are averages 
of triplicates. 
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the pN2HGF/SF expression vector. The dashed box represents the 
coding region for human HGF/SE (b) Immunoblot analysis. Condi- 
tioned media of HGF/SF producing clones A4 (lane 2), A1 (lane 
3), and parental cells (lane 4) were analyzed. Recombinant  human 
HGF/SF was blotted as a control (lane 1).  The molecular mass 
standards were phosphorylase b (94 kD), BSA (67 kD), ovalbumin 
(43 kD), and carbonic anhydrase (30 kD). 
SRa promoter (Fig. 1 a). This plasmid contains the neomy- 
cin phosphotransferase gene which confers (3418 resistance. 
The plasmid was introduced into the MDCK cells by elec- 
troporation, and clones resistant to 800/zg/ml of O418 were 
selected and expanded. The ability of the clones to secrete 
human HGF/SF into the culture medium was assayed by an 
ELISA which was sensitive enough to detect 0.3 ng/ml of 
HGF/SE 6  out of 17 clones secreted human HGF/SF at a 
concentration over 0.3 ng/ml per 24 h. To confirm that the 
molecules detected by ELISA were intact HGF/SF, the con- 
ditioned  media  from  two  clones  were  concentrated  by 
heparin-Sepharose  and  assayed by  immunoblotting.  The 
mAb used in this assay recognizes a peptide sequence in the 
heavy chain region of HGF/SF (Miyazawa et al.,  1991). As 
shown in Fig. 1 b, a band with a molecular mass of ,~,65 kD 
was detected in each clone. The molecular size corresponded 
to that of the heavy chain of recombinant human HGF/SF 
(Strain et al., 1991). The results indicated that the expression 
plasmid containing the sequence  of the cDNA  faithfully 
generated the intact form of HGF/SE 
Morphology and Motility of  HGF/SF Producing 
MDCK Cells 
All six clones that secreted significant quantities of HGFtSF 
exhibited  fibroblast-like  scattered morphology.  The  mor- 
phology of one of the HGF/SF producing clones is shown in 
Fig. 2. Another five clones exhibited the same fibroblast-like 
morphology (not shown). This morphology was similar to 
that of  MDCK cells treated exogenously  by HGF/SF, but was 
readily distinguishable from the parental MDCK cells. Four 
clones secreting varying levels of HGF/SF were further stud- 
ied (Table  fir). 
It was demonstrated by the Boyden chamber assay that the 
motility of MDCK cells was stimulated by HGF/SF (Stoker, 
1989). We used the same system to examine the motility of 
Figure 2. Morphology of transfected MDCK ceils. HGF/SF pro- 
ducing clone A1 (upper), and parental MDCK cells cultured with- 
out (middle) and  with 50  ng/ml recombinant human HGF/SF 
(lower). Cells were stained with Giemsa. Bar, 250/an. 
HGF/SF producing MDCK cells. As shown in Table II, the 
motility of all four clones significantly increased when com- 
pared with parental MDCK cells. 
Growth Properties of  HGF/SF Producing MDCK Cells 
Since exogenously added HGF/SF stimulated the growth of 
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Clone 
Number of  Number of 
Concentration  migrated  Saturation  colonies in 
of HGF/SF  cells*  densityw  soft agarH 
secreted*  (cells/mm  2)  (￿  105 cells/cm  2)  (Efficiency) 
ng/ml  % 
MDCK  0  70  +  6.7  4.0  0  (0) 
D4  0.6  331  -1- 29.5  3.0  0  (0) 
C4  1.2  329  +  40.1  3.7  2  (0.1) 
A1  3.3  389 + 31.8  3.8  10 (0.5) 
A4  6.9  215 5:34.3  4.5  27 (1.4) 
* The cells were grown m confluence and the secreted HGF/SF in 1 ml of the 
medium after 24 h culture was measured by ELISA. 
* Motility was assayed using Boyden chambers. Values are expressed as the 
mean +  SEM of two experiments performed in duplicate. 
w  The saturation density was determined by allowing cells to grow for 4 d after 
reaching confluence. 
If Colonies larger than 0.2 mm in diameter were counted after 28 d in culture. 
MDCK cells in soft agar, the growth characteristics of the 
HGF/SF producing MDCK cell clones were examined. Fig. 3 
shows the growth curves of  these clones and parental MDCK 
cells on culture dish. The two clones (D4 and A1) that secrete 
low or average levels of HGF/SF grew at a relatively high 
rate when compared with the parental MDCK cells. The 
clone (A4) that secretes a high level of HGF/SF grew slowly 
at low cell density. But when the density increased, it grew 
at high rate. Saturation densities of these clones were similar 
to those of parental MDCK cells regardless of their growth 
rate (Table [I). 
The three clones (A4, A1, and C4) secreting HGF/SF at 
levels of 1 ng/ml or higher efficiently grew in soft agar.  In 
contrast, growth in soft agar of the clone (134) that secretes 
HGF/SF at a lower level (~0.6 ng/ml) was slow and all the 
colonies were smaller than 0.2 mm in diameter after 28 d in 
culture even though they are larger than those of parental 
MDCK cells. The number of colonies larger than 0.2 mm in 
diameter  correlated  roughly  with  the  level  of  HGF/SF 
secreted (Table l]). 
To directly assess the effect of HGF/SF production on the 
in vivo growth properties of  the cells, the HGF/SF producing 
clones were inoculated subcutaneously in nude mice. The 
clones,  which  acquired  efficient  anchorage-independent 
growth in soft agar (Table 11), failed to induce tumor even 
when as many as 107 cells were inoculated. The results in- 
dicated that HGF/SF has no direct effect on the growth of 
MDCK cells in vivo. 
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Figure 3.  Growth curves of 
HGF/SF  producing clones. 
Ceils were seeded at 1 x  104 
ceils  per  35-mm dish  and 
grown in DME supplemented 
with 5 % FBS. The cells were 
counted every 2 d. Each point 
represents the mean of  two ex- 
periments performed in dupli- 
cate. (=) Clone A4; (e) clone 
A1; (&) clone IM; (o) paren- 
tal MDCK. 
Effect of  Anti-HGF/SF  Antibody on HGF/SF 
Producing MDCK Cells 
To test whether autocrine production of HGF/SF was respon- 
sible for some of  the phenotypic features of HGF/SF produc- 
ing MDCK cells,  we analyzed the effects  of an antibody 
raised against human HGF/SE In the presence of anti-HGF/ 
SF polyclonal antibody, the HGF/SF producing MDCK cells 
were less well scattered (Fig. 4). In addition, the antibody 
inhibited growth stimulation in  soft agar by exogenously 
added HGF/SF as well as efficient growth in soft agar of the 
HGF/SF producing MDCK cells. However, the antibody did 
not prevent growth stimulation by exogenously added EGF 
(Fig. 4 and Table ill). The migration of HGF/SF producing 
MDCK cells was not prevented in the presence of the anti- 
body (Table IV). 
Discussion 
The results presented here demonstrate that human HGF/SF 
synthesized after transfection of MDCK epithelial cells in- 
duces changes in cell morphology from an epithelial to a 
fibroblastic  type,  cell  motility  and  efficient  anchorage- 
independent growth in soft agar. All the clones which secrete 
HGF/SF at over 0.6 ng/ml exhibited fibroblast-like scattered 
morphology. The scattered cells were converted to form co- 
hesive colonies in the presence of anti-HGF/SF antibody in 
the culture medium.  Thus, the secretion of HGF/SF was 
necessary for the conversion from epithelial to fibroblastic 
morphology. Stoker et al. (1987) have shown that HGF/SF 
was produced by embryo fibroblasts and by certain fibroblast 
lines, and that most epithelial cells were sensitive to its activ- 
ity.  Their  results  implied  that  HGF/SF  affects  mesen- 
chymal-epithelial interactions in a paracrine fashion. Adams 
et al. (1991) found that ndk cells, a strain of  human epidermal 
kerafinocytes, produced HGF/SF and grew as single cells 
rather than as compact colonies. They also found that sura- 
mine, a polyanionic detergent, caused the ndk cells to grow 
in cohesive patches. From these findings, they proposed that 
the motile phenotype of ndk cells is due, at least in part, to 
autocrine production of  HGF/SE Our results showed that the 
fibroblastic morphology of MDCK epithelial cells was due 
to autocrine production of HGF/SE It is therefore suggested 
that  autocrine production of HGF/SF  is  involved in  the 
fibroblastic phenotype. Stoker et al. 0989) demonstrated by 
Boyden chamber assays that fibroblasts showed high sponta- 
neous motility and they suggested that HGF/SF is operating 
in  these  cells  in  an  autocrine manner.  However,  further 
studies  will be  required  to  investigate whether  HGF/SF 
production in fibroblasts influences their phenotype. 
MDCK cell clones that secrete higher levels (1.2 ng/ml or 
higher) of HGF/SF acquired highly efficient growth proper- 
ties in soft agar.  This efficient growth was inhibited in the 
presence of anti-HGF/SF antibody, indicating that secretion 
of HGF/SF is required for efficient growth in soft agar.  The 
efficient anchorage-independent growth is generally consid- 
ered a property concomitant with the transformed pheno- 
type. However,  the clones that efficiently grew in soft agar 
did not form tumors in nude mice. Thus, they do not have 
properties of tumorigenic cells in vivo. These observations 
imply that the efficient growth of the cells in soft agar may 
not reflect the direct role of HGF/SF secretion as a growth 
The Journal of Cell Biology, Volume 117,  1992  892 Figure 4. Conversion of  phenotypes  by anti-HGF/SF antibody. A HGF/SF producing clone (A4) was examined for the morphology in mono- 
layers (upper) and for colony formation in soft afar (lower). Ceils were incubated for 2 d in monolayers or for 28 d in soft agar with 0.5 % 
anti-HGF/SF antiserum (right) or 0.5%  normal rabbit serum (left).  Bar, 250/~m. 
factor,  but rather an indirect  enhancing  effect through  scat- 
tering  activity.  Dissociated and motile cells probably have 
the ability to efficiently grow in semisolid medium, whereas 
the efficient growth of normal epithelial  cells is restricted 
probably because of tight junctions.  The number of large 
colonies (larger than 0.2 mm in diameter after 28 d culture) 
correlated roughly with the level of secreted HGF/SF, and 
the clone (D4) which secreted lower levels  (0.6 ng/ml)  of 
HGF/SF failed to form large colonies, even though all these 
clones exhibited  similar  scattered  morphology in  culture 
dishes. The level of HGF/SF secretion may influence scatter- 
ing activity in soft agar. 
Table III. Inhibition of Colony Formation in Soft Agar by 
Anti-HGF/SF  Antiserum 
Cells 
Number of colonies  Number  of colonies 
in the presence of  in the presence of 
0.5% control  0.5% anti-HGF/SF 
serum  antiserum 
MDCK (100  ng/ml HGF/SF)  35  3 
MDCK (50 ng/ml EGF)  66  61 
clone A1  11  2 
clone A4  28  5 
The motility of the HGF/SF producing MDCK cell clones 
was not prevented  by the anti-HGF/SF antibody.  Thus, the 
migration may be affected by intracellular  action of HGF/SE 
Alternatively,  secreted HGF/SF may not have been com- 
pletely neutralized  by the antibody and the small amount of 
HGF/SF in the medium may affect the migration  of MDCK 
cells. 
Table IV. Migration of Cells in the Presence of 
Anti-HGF/SF  Antiserum 
Number of migrated  Number  of migrated cells 
cells in the presence  in the presence of 0.5% 
Cells  of 0.5% control serum  anti-HGF/SF antiserum 
MDCK 
(10 ng/ral HGF/SF)*  191  +  20.2 
clone D4  221  +  40.8 
clone C4  324  +  17.4 
clone A1  353  +  37.2 
clone A4  227  +  18.5 
53  :[:  10.4 
203  +  47.1(247  5: 66.6) 
298  +  22.5(317  5:  18.4) 
341  +  27.6(352  5: 28.3) 
220  +  22.8(216  +  24.4) 
Control serum or antiserum was added to both upper and lower wells. Values 
are expressed as the mean -1- SEM of  two experiments  performed in duplicate. 
Cells cultured for 2 d in the presence  of  antiserum  were used for the assay shown 
in parenthesis. 
* The concentration of HGF/SF required for a maximal response was  10 
ng/mi. The factor was present in both wells. 
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age-independent growth were prevented by anti-HGF/SF an- 
tibody, suggesting that the secreted HGF/SF exerts its effects 
through  receptors  on the cell  surface.  Little  is known of 
HGF/SF receptor  molecules on MDCK cell  surface.  Re- 
cently, Bottaro et al. (1991) identified a HGF/SF receptor in 
a  human mammary epithelial  cell  line,  whose growth  is 
stimulated  by HGF/SF,  as the c-met proto-oncogene prod- 
uct. The c-met proto-oncogene encodes a 1408 amino acid 
protein  with features  characteristic  of the tyrosine  kinase 
family  of growth  factor receptors  (Park et al.,  1987).  We 
have identified a HGF/SF binding 160-kD protein on the sur- 
face of MDCK cells  which is probably  the c-met proto- 
oncogene product (M.  Komada and N.  Kitamura,  unpub- 
lished  results).  Thus,  the  c-met  proto-oncogene product 
might be involved in the scattering of MDCK cells by HGF/ 
SF. Further characterization  of the receptor  as well as the 
molecules involved in intracellular  signal  cascades will be 
required to understand the molecular mechanisms responsi- 
ble for the action of HGF/SF on MDCK cells. The HGF/SF 
producing cell clones which we have established in this study 
will be useful for such studies. 
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